Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors

Peitao Zhang(Pingliang People's Hospital), Li Zhao(United States Geological Survey)
Nature Communications
March 24, 2022
Cited by 85


Related Papers